User profiles for G. Girolomoni
Giampiero GirolomoniUniversity of Verona Verified email at univr.it Cited by 42499 |
[HTML][HTML] Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions
…, M Ståhle, FO Nestle, G Girolomoni… - Journal of Investigative …, 2010 - Elsevier
Psoriasis is now classified as an immune-mediated inflammatory disease (IMID) of the skin.
It is being recognized that patients with various IMIDs, including psoriasis, are at higher risk …
It is being recognized that patients with various IMIDs, including psoriasis, are at higher risk …
European consensus statement on phenotypes of pustular psoriasis
…, K Ghoreschi, M Gilliet, G Girolomoni… - Journal of the …, 2017 - Wiley Online Library
Pustular psoriasis ( PP ) is a group of inflammatory skin conditions characterized by infiltration
of neutrophil granulocytes in the epidermis to such an extent that clinically visible sterile …
of neutrophil granulocytes in the epidermis to such an extent that clinically visible sterile …
[HTML][HTML] The epidermal growth factor receptor system in skin repair and inflammation
S Pastore, F Mascia, V Mariani, G Girolomoni - Journal of Investigative …, 2008 - Elsevier
… In addition, the EGFR can be activated by transactivation from a variety of G-protein-coupled
receptors, integrins, and cytokine receptors, so that it acts as the major transducer of …
receptors, integrins, and cytokine receptors, so that it acts as the major transducer of …
Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I
…, A Fink‐Wagner, U Gieler, G Girolomoni… - Journal of the …, 2018 - Wiley Online Library
… G. Girolomoni has been an advisor, speaker or investigator for AbbVie, Abiogen, Allmirall,
Amgen, Bayer, Biogen, Boehringer Ingelheim, Celgene, Eli Lilly, Galderma, Hospira, Janssen, …
Amgen, Bayer, Biogen, Boehringer Ingelheim, Celgene, Eli Lilly, Galderma, Hospira, Janssen, …
Prevalence of metabolic syndrome in patients with psoriasis: a hospital‐based case–control study
…, A Peserico, A Giannetti, G Girolomoni - British Journal of …, 2007 - academic.oup.com
Background Psoriasis is a chronic inflammatory disease associated with an increased
cardiovascular risk. Metabolic syndrome is a significant predictor of cardiovascular events. …
cardiovascular risk. Metabolic syndrome is a significant predictor of cardiovascular events. …
European S3-guidelines on the systemic treatment of psoriasis vulgaris
…, R Erdmann, J Ferguson, G Girolomoni… - Journal of the …, 2009 - art.torvergata.it
… The risk for hepatotoxicity seems to increase further after a cumulative dosage of >3 g
methotrexate and /or >100 g/week of alcohol consumption.The assessment of the risk of …
methotrexate and /or >100 g/week of alcohol consumption.The assessment of the risk of …
Epidemiology of atopic dermatitis in adults: results from an international survey
S Barbarot, S Auziere, A Gadkari, G Girolomoni… - Allergy, 2018 - Wiley Online Library
… G. Girolomoni has been principal investigator in clinical trials sponsored by and/or and has
received personal fees from AbbVie, Abiogen, Almirall, Amgen, Bayer, Biogen, Celgene, Eli-…
received personal fees from AbbVie, Abiogen, Almirall, Amgen, Bayer, Biogen, Celgene, Eli-…
Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II
…, A Fink‐Wagner, U Gieler, G Girolomoni… - Journal of the …, 2018 - Wiley Online Library
… G. Girolomoni has been an advisor, speaker or investigator for AbbVie, Abiogen, Almirall,
Amgen, Bayer, Biogen, Boehringer Ingelheim, Celgene, Eli Lilly, Galderma, Hospira, Janssen, …
Amgen, Bayer, Biogen, Boehringer Ingelheim, Celgene, Eli Lilly, Galderma, Hospira, Janssen, …
European guideline (EuroGuiDerm) on atopic eczema: part I–systemic therapy
…, L Gerbens, U Gieler, G Girolomoni… - Journal of the …, 2022 - Wiley Online Library
The evidence‐ and consensus‐based guideline on atopic eczema was developed in
accordance with the EuroGuiDerm Guideline and Consensus Statement Development Manual. …
accordance with the EuroGuiDerm Guideline and Consensus Statement Development Manual. …
Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey
…, H Bachelez, J Barker, G Girolomoni… - Journal of the American …, 2014 - Elsevier
Background Available psoriasis surveys offer valuable information about psoriasis and psoriatic
arthritis (PsA), but are limited by methodology or enrollment requirements. Objective To …
arthritis (PsA), but are limited by methodology or enrollment requirements. Objective To …